Review

Nature Reviews Cancer 8, 865-873 (November 2008) | doi:10.1038/nrc2502

Article series: Hypoxia and metabolism

The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer

William G. Kaelin Jr1  About the author

Top

The von Hippel–Lindau disease is caused by inactivating germline mutations of the VHL tumour suppressor gene and is associated with an increased risk of a variety of tumours in an allele-specific manner. The role of the heterodimeric transcription factor hypoxia-inducible factor (HIF) in the pathogenesis of VHL-defective tumours has been more firmly established during the past 5 years. In addition, there is now a greater appreciation of HIF-independent VHL functions that are relevant to tumour development, including maintenance of the primary cilium, regulation of extracellular matrix formation and turnover, and modulation of cell death in certain cell types following growth factor withdrawal or in response to other forms of stress.

Author affiliations

  1. Howard Hughes Medical Institute, Chevy Chase, Maryland 20815-6789, USA, and Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
    Email: William_Kaelin@dfci.harvard.edu

Published online 16 October 2008

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

HIF, a missing link between metabolism and cancer

Nature Medicine News and Views (01 Oct 2005)

A hypoxic twist in metastasis

Nature Cell Biology News and Views (01 Mar 2008)

See all 4 matches for News And Views

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

Search PubMed for

naturejobs

natureproducts


Advertisement